HUP0001531A3 - Anthranilic acid derivatives as multi drug resistance modulators - Google Patents
Anthranilic acid derivatives as multi drug resistance modulatorsInfo
- Publication number
- HUP0001531A3 HUP0001531A3 HU0001531A HUP0001531A HUP0001531A3 HU P0001531 A3 HUP0001531 A3 HU P0001531A3 HU 0001531 A HU0001531 A HU 0001531A HU P0001531 A HUP0001531 A HU P0001531A HU P0001531 A3 HUP0001531 A3 HU P0001531A3
- Authority
- HU
- Hungary
- Prior art keywords
- acid derivatives
- drug resistance
- anthranilic acid
- multi drug
- resistance modulators
- Prior art date
Links
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical class NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 title 1
- 230000036457 multidrug resistance Effects 0.000 title 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9602552 | 1996-10-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0001531A2 HUP0001531A2 (hu) | 2000-08-28 |
HUP0001531A3 true HUP0001531A3 (en) | 2000-09-28 |
Family
ID=10788338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0001531A HUP0001531A3 (en) | 1996-10-18 | 1997-10-17 | Anthranilic acid derivatives as multi drug resistance modulators |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN100354265C (hu) |
HU (1) | HUP0001531A3 (hu) |
ZA (1) | ZA979329B (hu) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4464814B2 (ja) * | 2002-05-14 | 2010-05-19 | アバーント・ファーマシューティカルズ・(インディア)・リミテッド | アントラニル酸誘導体の水和物の製造方法 |
CN103764649B (zh) * | 2011-08-26 | 2016-10-19 | 拜耳知识产权有限责任公司 | 通过苯并噁嗪酮与胺反应制备四唑取代的邻氨基苯甲酸二酰胺衍生物的方法 |
CN102603630B (zh) * | 2012-03-12 | 2014-08-20 | 北京科技大学 | 邻氨基苯甲酸磺酰化衍生物及其制备方法和应用 |
EP3004083A4 (en) * | 2013-05-24 | 2016-11-16 | California Inst Biomedical Res | COMPOUNDS FOR THE TREATMENT OF DRUG RESISTANT AND PERSISTENT TUBERCULOSIS |
CN104434947B (zh) * | 2014-11-07 | 2016-11-09 | 滨州医学院附属医院 | 一种抗胆管癌的药物组合物及其应用 |
CN104910069B (zh) * | 2014-12-15 | 2018-03-23 | 北京科技大学 | 氨茴酸类衍生物、其制备方法及其在医药上的用途 |
CN112724124A (zh) * | 2021-01-18 | 2021-04-30 | 林剑雄 | 4-羟基喹啉类衍生物及其制备方法和在抗肿瘤药物中的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0649410T3 (da) * | 1992-07-10 | 1997-09-15 | Glaxo Lab Sa | Anilidderivater. |
AU5813394A (en) * | 1992-12-23 | 1994-07-19 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Anellated uracil derivates |
GB9426224D0 (en) * | 1994-12-23 | 1995-02-22 | Xenova Ltd | Pharmaceutical compounds |
-
1997
- 1997-10-17 CN CNB971807086A patent/CN100354265C/zh not_active Expired - Fee Related
- 1997-10-17 HU HU0001531A patent/HUP0001531A3/hu unknown
- 1997-10-17 ZA ZA979329A patent/ZA979329B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0001531A2 (hu) | 2000-08-28 |
CN100354265C (zh) | 2007-12-12 |
ZA979329B (en) | 1999-04-19 |
CN1241181A (zh) | 2000-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4400797A (en) | Colon selective drug delivery composition | |
AU1225000A (en) | Combined pharmaceutical estrogen-androgen-progestin | |
AU1071301A (en) | Pharmaceutical compounds | |
HU9801044D0 (en) | Sulfonyl-amino-carboxylic acid derivatives | |
AU6740298A (en) | Pharmaceutical composition | |
HUP0003881A3 (en) | Amidocarboxylic acid derivatives | |
AU1267400A (en) | Pharmaceutical moxifloxacin preparation | |
AU6062498A (en) | Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use | |
AU1559199A (en) | Isothiazolcarboxylic acid derivatives | |
AU1409100A (en) | Drugs | |
AU8591898A (en) | Pharmaceutical compounds | |
ZA982073B (en) | Pharmaceutical preparation | |
HUP0001531A3 (en) | Anthranilic acid derivatives as multi drug resistance modulators | |
AU9343098A (en) | Pharmaceutical composition | |
AUPQ365299A0 (en) | Anthranilic acid derivatives | |
AU5722900A (en) | Pharmaceutical compounds | |
IL122920A (en) | Castrointestinal drug composition | |
AUPP332898A0 (en) | Pharmaceutical composition | |
AU6480299A (en) | Pharmaceutical compounds | |
AU5067498A (en) | Biphenyl derivatives and drug composition | |
AU1688099A (en) | Pharmaceutical preparation | |
HUP0101341A3 (en) | New drug combinations | |
HUP0004132A3 (en) | Rapidly soluble drug composition | |
AU5429699A (en) | Drug targeting | |
AU5184599A (en) | Pharmaceutical compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |